Literature DB >> 28137690

Cost-effectiveness of rituximab strategies in rheumatoid arthritis.

Raphaèle Seror1, Xavier Mariette2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28137690     DOI： 10.1016/S0140-6736(17)30053-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

1.  Low-dose rituximab protocol in rheumatoid arthritis-outcome and economic impact.

Authors:  Parvathypriya Chandramohan; Avinash Jain; Glindow Antony; Narayanan Krishnan; Padmanabha Shenoy
Journal:  Rheumatol Adv Pract       Date:  2021-01-07

2.  Experience With the Use of Rituximab for the Treatment of Rheumatoid Arthritis in a Tertiary Hospital in Spain: RITAR Study.

Authors:  Iciar Cañamares; Leticia Merino; Jorge López; Irene Llorente; Alberto García-Vadillo; Esther Ramirez; Juan Pedro López-Bote; Juana Benedí; Cecilia Muñoz-Calleja; José M Álvaro-Gracia; Santos Castañeda; Isidoro González-Álvaro
Journal:  J Clin Rheumatol       Date:  2019-09       Impact factor: 3.517
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.